334 related articles for article (PubMed ID: 10989266)
1. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in the subjective effects of MDMA.
Liechti ME; Gamma A; Vollenweider FX
Psychopharmacology (Berl); 2001 Mar; 154(2):161-8. PubMed ID: 11314678
[TBL] [Abstract][Full Text] [Related]
3. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
Morley KC; Arnold JC; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
[TBL] [Abstract][Full Text] [Related]
4. Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.
Liechti ME; Vollenweider FX
Eur Neuropsychopharmacol; 2000 Jul; 10(4):289-95. PubMed ID: 10871712
[TBL] [Abstract][Full Text] [Related]
5. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
Fletcher PJ; Korth KM; Robinson SR; Baker GB
Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
[TBL] [Abstract][Full Text] [Related]
6. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Fantegrossi WE; Godlewski T; Karabenick RL; Stephens JM; Ullrich T; Rice KC; Woods JH
Psychopharmacology (Berl); 2003 Mar; 166(3):202-11. PubMed ID: 12563544
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
9. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.
Vollenweider FX; Gamma A; Liechti M; Huber T
Neuropsychopharmacology; 1998 Oct; 19(4):241-51. PubMed ID: 9718588
[TBL] [Abstract][Full Text] [Related]
10. Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects.
Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME
ACS Chem Neurosci; 2019 Jul; 10(7):3120-3131. PubMed ID: 30589533
[TBL] [Abstract][Full Text] [Related]
11. MDMA-induced indifference to negative sounds is mediated by the 5-HT
Kuypers KPC; de la Torre R; Farre M; Pizarro N; Xicota L; Ramaekers JG
Psychopharmacology (Berl); 2018 Feb; 235(2):481-490. PubMed ID: 28735368
[TBL] [Abstract][Full Text] [Related]
12. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
Liechti ME; Geyer MA; Hell D; Vollenweider FX
Neuropsychopharmacology; 2001 Mar; 24(3):240-52. PubMed ID: 11166515
[TBL] [Abstract][Full Text] [Related]
13. Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.
Liechti ME; Vollenweider FX
Hum Psychopharmacol; 2001 Dec; 16(8):589-598. PubMed ID: 12404538
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans.
Gamma A; Buck A; Berthold T; Liechti ME; Vollenweider FX
Neuropsychopharmacology; 2000 Oct; 23(4):388-95. PubMed ID: 10989265
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G
Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162
[TBL] [Abstract][Full Text] [Related]
16. The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Tancer M; Johanson CE
Psychopharmacology (Berl); 2007 Jan; 189(4):565-73. PubMed ID: 17047932
[TBL] [Abstract][Full Text] [Related]
17. 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats.
Blessing WW; Seaman B
Neuroscience; 2003; 117(4):939-48. PubMed ID: 12654345
[TBL] [Abstract][Full Text] [Related]
18. Influence of ketanserin on the effects of methylenedioxymethamphetamine on body temperature in the mouse.
Docherty JR; Bexis S
Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):35-41. PubMed ID: 23906337
[TBL] [Abstract][Full Text] [Related]
19. α₁-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans.
Hysek CM; Fink AE; Simmler LD; Donzelli M; Grouzmann E; Liechti ME
J Clin Psychopharmacol; 2013 Oct; 33(5):658-66. PubMed ID: 23857311
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy.
Alvaro AR; Martins J; Costa AC; Fernandes E; Carvalho F; Ambrósio AF; Cavadas C
Neuroscience; 2008 Mar; 152(1):97-105. PubMed ID: 18249070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]